Navigation Links
Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
Date:10/29/2013

ntries in South East Asia. To date 10 of 22 sites have been activated with all sites expected to be actively screening patients by the end of the year.  After the first 48 patients have completed eight weeks of treatment, the Company plans to conduct an interim analysis to determine the effect of blisibimod on proteinuria and other relevant biomarkers such as IgA and IgG levels in early 2014.Regulatory

In May 2013, the Company met with the US FDA to discuss the IgA nephropathy development program for blisibimod. As a result of receiving feedback from the US FDA on the potential use of a change in proteinuria as the endpoint for Subpart E approval for blisibimod, the Company has amended the BRIGHT-SC study endpoints accordingly.  Upon implementation of this new amendment it is the Company's intention to use the BRIGHT-SC study as one of two studies necessary to support the marketing approval of blisibimod for the treatment of IgA nephropathy under the accelerated approval pathway (US FDA Subpart E).  In addition, the US FDA indicated a requirement for the Company to provide data from a post-marketing study which would include measurements of clinical endpoints, such as changes in kidney function, progression to dialysis and death in patients previously enrolled in the two registration studies.

In June 2013, we met with the Japanese Pharmaceutical and Medical Devices Agency, or PMDA to discuss the development of blisibimod for the treatment of IgA nephropathy in Japan.  At this initial meeting the PMDA also agreed to consider change in proteinuria as the basis for an initial approval of blisibimod for the treatment of IgA nephropathy.  Further discussions with the PMDA regarding development of blisibimod in Japan are planned for early 2014.

Prior to the end of 2013, the Company plans to submit an Investigational New Drug application, or IN
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
2. Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
3. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
4. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
5. Anthera Pharmaceuticals Announces Personnel Changes
6. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
7. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
8. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
9. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
10. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
11. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., (NASDAQ: ... today that clinical data presented at the 2015 ... urine-based Precision Cancer Monitoring ℠ (PCM) platform ... of EGFR T790M mutations in metastatic ... of EGFR T790M Mutation in Urinary Circulating Tumor ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) ... Systems - Global Strategic Business Report" report to ... markets for Medical Oxygen Systems in US$ Thousands by ... Cylinders & Regulators, and Oxygen Conserving Devices. The report ... Canada , Japan , ...
(Date:4/17/2015)... Today, the Pharmaceutical Research and Manufacturers ... biopharmaceutical companies as "We Work For Health Champions" ... community service. Established in 2009, the ... by the biopharmaceutical industry to honor employees who ... have also shown an outstanding commitment to their ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced ... of Unit Dose Budesonide (UDB) for the potential,treatment ... that the clinical,trial did not meet its co-primary ... in nighttime and daytime composite symptom scores, in,either ...
... 23 BN,ImmunoTherapeutics, Inc. today provided updated data ... MVA-BN(R)-HER2, in development as,therapy of metastatic breast cancer ... primary endpoint with regards to safety and by ... response was,detected in approximately 70% of evaluated patients. ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 2MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 3BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 2BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 3
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will be ... The event will be held in the heart of downtown ... NW, Grand Rapids, MI 49503) and will feature wine personalities ... are encouraged to savor the food and beverage pairings while ... event will feature seven chefs, including:, ...
(Date:4/17/2015)... Most dental patients are not aware that ... overseas by foreign dental laboratories, according to the U.S. ... more than 40 states by their respective state boards ... Laboratories has created the “What’s In Your ... the consequences that could be associated with using poorly-made ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
Breaking Medicine News(10 mins):Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:National Association Urges Transparency in Dental Industry 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3
... Nigam, a top-notch Hindi singer, says that men are ... s managed to catch the attentions of many people. Sonu ... harassing him for sexual favors in return for publicity. ... now was employed against the girls in the industry. ...
... talked up the virtues of dog meat, saying the controversial ... heat . ,Dog soup, called dangogi-jang or boshintang ... season, the official Korean Central News Agency said, touting its ... an euphemism for dog meat that was coined by North ...
... UN experts, food safety is an issue for every country ... the almost 200 food safety incidents that occurred in the ... all countries to be vigilant when dealing with traders and ... examples, the Food and Agriculture Organization (FAO) and the World ...
... the University Clinic of the University of Navarra have ... adult stem cell growth for its capacity to ... ,Ana Fernandez Hortelano, ophthalmologist at the hospital, applied ... cornea in 70 rabbits for the purpose of regaining ...
... finasteride, a drug proven effective in preventing prostate cancer, just ... bedroom, can now put their fears to rest, thanks to ... the Southwest Oncology Group, found that though the drug does ... the course of time. ,As a part of ...
... antidepressants, and if so, should they be given ... by the National Institute for Health and Clinical ... bmj.com last month found that adding cognitive behaviour ... treatment is unlikely to improve outcomes for adolescents ...
Cached Medicine News:Health News:Male Casting Couch in Bollywood? 2Health News:Male Casting Couch in Bollywood? 3Health News:Gaps In Food Safety Systems Must Be Plugged :UN 2Health News:Mens Sexual Prowess Not Affected by Prostate Cancer Drug 2Health News:New Study Challenges NICE Guidelines on Adolescent Depression 2
As pupil size continues to play a significant role in the outcomes of refractive surgery, the pre-operative use of the Colvard Pupillometer continues to be the standard of care for obtaining accurate...
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
...
Medicine Products: